ReviewJournal of bone oncology2017

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.

Peyman Hadji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.